CNTA
Centessa Pharmaceuticals plcCompany with tickers: CNTA
CIK
1847903
CUSIP
152309100
Shares Outstanding
154,728,966
13F Activity (30d)
122 filings
121 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $-79,773,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-79,241,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-0.52 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-0.52 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |